Introducing our partnership with Antibiotic Action

26 May 2015
Written by
Longitude team

Antibiotic Action is an independent UK-led global initiative wholly funded by the British Society for Antimicrobial Chemotherapy (BSAC), which is a UK registered charity. Antibiotic Action seeks to inform and educate all about the need for discovery, research and development of new treatments for bacterial infections. It contributes to national and international activities and acts as a conduit through which all stakeholders are educated on the importance of new ways to treat bacterial infections. It is led by Professor Laura JV Piddock, BSAC Chair in Public Engagement and Professor of Microbiology, University of Birmingham.

Antibiotic Action is overseen by an Advisory Group comprising antibiotic experts from academic research, pharmaceutical industry, regulation, clinical practice, international affairs and patients. Antibiotic Action is now a key player on the global stage, working alongside colleagues in Europe, the United States and further afield.  We are working to identify how all sectors can be informed of the crisis of no new antibiotics and the need to use antibiotics properly, and to identify the opportunities that exist for discovery, research, and development to ensure new treatments for microbial infections.  It is vital to the health of all nations that antibiotics remain the mainstay of modern medicine and are available to all who need them.

Antibiotic Action is happy to announce a new partnership with the Longitude Prize 2015. The initiatives will work together to raise awareness about antibiotic resistance, and promote research into ways in which this global public health crisis can be tackled.